UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

Arthritis research & therapy, 2021-10, Vol.23 (1), p.269-11, Article 269

2021

Volltextzugriff (PDF)

Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response

Annals of the rheumatic diseases, 2022-10, Vol.81 (10), p.1385-1391

2022

Volltextzugriff (PDF)

1279-P: The INNODIA Natural History Study of Children, Adolescents, and Adults Newly Diagnosed with Type 1 Diabetes

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

Arthritis research & therapy, 2021-11, Vol.23 (1), p.1-285, Article 285

2021

Volltextzugriff (PDF)

The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups

BMC musculoskeletal disorders, 2021-08, Vol.22 (1), p.1-746, Article 746

2021

Volltextzugriff (PDF)

Patient‐Reported Outcome Data From an Early Rheumatoid Arthritis Trial: Opportunities for Broadening the Scope of Treating to Target

Arthritis care & research (2010), 2019-12, Vol.71 (12), p.1566-1575

2019

Volltextzugriff (PDF)

JAK inhibition and the holy grail for pain control in early RA

Rheumatic & musculoskeletal diseases open, 2022-01, Vol.8 (1), p.e002068

2022

Volltextzugriff (PDF)

Effectiveness and feasibility of a mobile health self-management intervention in rheumatoid arthritis: study protocol for a pragmatic multicentre randomised controlled trial (AEGORA)

Trials, 2023-10, Vol.24 (1), p.697-697, Article 697

2023

Volltextzugriff (PDF)

Engagement and attrition with eHealth tools for remote monitoring in chronic arthritis: a systematic review and meta-analysis

Rheumatic & musculoskeletal diseases open, 2022-10, Vol.8 (2), p.e002625

2022

Volltextzugriff (PDF)

To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis

Therapeutic advances in musculoskeletal disease, 2024-01, Vol.16, p.1759720X241232268-1759720X241232268

2024

Volltextzugriff (PDF)

Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT

Clinical rheumatology, 2020-09, Vol.39 (9), p.2593-2601

2020

Volltextzugriff (PDF)

One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment

Rheumatic & musculoskeletal diseases open, 2020-04, Vol.6 (1), p.e001146

2020

Volltextzugriff (PDF)

Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis Replication

Journal of rheumatology, 2022-04, Vol.49 (4), p.436-437

2022

Volltextzugriff (PDF)

Prescribing anti-rheumatic drugs in pregnancy and breastfeeding—the British Society for Rheumatology guideline scope

Rheumatology (Oxford, England), 2022-02, Vol.61 (2), p.480-481

2022

Volltextzugriff (PDF)

Comorbidities in Early Psoriatic Arthritis: Data From the Metabolic Disturbances in Psoriatic Arthritis Cohort Study

Arthritis care & research (2010), 2024-02, Vol.76 (2), p.231-240

2024

Volltextzugriff (PDF)

Viewpoint: Supporting mental health in the current management of rheumatoid arthritis: time to act

Rheumatology (Oxford, England), 2023-10, Vol.62 (SI3), p.SI274-SI281

2023

Volltextzugriff (PDF)

Correspondence on ‘EULAR recommendations for a core data set for pregnancy registries in rheumatology’

Annals of the rheumatic diseases, 2023-02, Vol.82 (2), p.e44-e44

2023

Volltextzugriff (PDF)

Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well‐Being and Disease Activity

Arthritis care & research (2010), 2023-04, Vol.75 (4), p.758-767

2023

Volltextzugriff (PDF)

Undifferentiated arthritis, not just another early manifestation of rheumatoid arthritis

Rheumatology (Oxford, England), 2022-08, Vol.61 (8), p.3101-3103

2022

Volltextzugriff (PDF)

Glucocorticoids in rheumatoid arthritis: Balancing benefits and harm by leveraging the therapeutic window of opportunity

Joint, bone, spine : revue du rhumatisme, 2023-05, Vol.90 (3), p.105491-105491, Article 105491

2023

Volltextzugriff (PDF)

Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial

Annals of the rheumatic diseases, 2021-08, Vol.80 (8), p.965-973

2021

Volltextzugriff (PDF)

New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis

Rheumatology (Oxford, England), 2022-12, Vol.62 (1), p.108-115

2022

Volltextzugriff (PDF)

Response to: ‘Correspondence on ‘Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial’’ by Jain and Dhir et al

Annals of the rheumatic diseases, 2023-07, Vol.82 (7), p.e163-e163

2023

Volltextzugriff (PDF)

Comment on: what is the best treatment for early rheumatoid arthritis?

Rheumatology (Oxford, England), 2021-05, Vol.60 (5), p.e177-e178

2021

Volltextzugriff (PDF)

Glucocorticoïdes et polyarthrite rhumatoïde : trouver l’équilibre bénéfice–préjudice en exploitant la fenêtre d’opportunité thérapeutique

Revue du rhumatisme (Ed. française : 1993), 2023-10, Vol.90 (5), p.565-574

2023

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Rheumatology
(34)
Rheumatoid Arthritis
(24)
Humans
(17)
Patients
(16)
Arthritis, Rheumatoid - Drug Therapy
(10)
Antirheumatic Agents - Therapeutic Use
(9)
Arthritis
(9)
Remission
(9)
Glucocorticoids
(8)
Patient Reported Outcome Measures
(8)
Disease Control
(7)
Female
(6)
Pain
(6)
Rheumatoid
(6)
Severity Of Illness Index
(6)
Sociology
(6)
Treatment Outcome
(6)
Medical Prognosis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response

1279-P: The INNODIA Natural History Study of Children, Adolescents, and Adults Newly Diagnosed with Type 1 Diabetes

Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups

Patient‐Reported Outcome Data From an Early Rheumatoid Arthritis Trial: Opportunities for Broadening the Scope of Treating to Target

JAK inhibition and the holy grail for pain control in early RA

Effectiveness and feasibility of a mobile health self-management intervention in rheumatoid arthritis: study protocol for a pragmatic multicentre randomised controlled trial (AEGORA)

Engagement and attrition with eHealth tools for remote monitoring in chronic arthritis: a systematic review and meta-analysis

To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis

Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT

One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment

Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis Replication

Prescribing anti-rheumatic drugs in pregnancy and breastfeeding—the British Society for Rheumatology guideline scope

Comorbidities in Early Psoriatic Arthritis: Data From the Metabolic Disturbances in Psoriatic Arthritis Cohort Study

Viewpoint: Supporting mental health in the current management of rheumatoid arthritis: time to act

Correspondence on ‘EULAR recommendations for a core data set for pregnancy registries in rheumatology’

Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well‐Being and Disease Activity

Undifferentiated arthritis, not just another early manifestation of rheumatoid arthritis

Glucocorticoids in rheumatoid arthritis: Balancing benefits and harm by leveraging the therapeutic window of opportunity

Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial

New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis

Response to: ‘Correspondence on ‘Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial’’ by Jain and Dhir et al

Comment on: what is the best treatment for early rheumatoid arthritis?

Glucocorticoïdes et polyarthrite rhumatoïde : trouver l’équilibre bénéfice–préjudice en exploitant la fenêtre d’opportunité thérapeutique

Suchergebnisse filtern